Accelerate Diagnostics, Inc: Nasdaq/NYSE listing notice — Accelerate Diagnostics receives Nasdaq delisting notice for bid price below $1.00

Accelerate Diagnostics, Inc

On April 26, 2024, Nasdaq notified Accelerate Diagnostics that its bid price closed below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until Oct 23, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant by Oct 23, company may be eligible for additional 180-day extension if it meets other listing standards.
Company considering options including a reverse stock split; no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Accelerate Diagnostics, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 26, 2024, Accelerate Diagnostics, Inc. (the “Company”) received written notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock had closed below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or unti

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-24-055019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.